How Will Amneal Pharmaceuticals Inc. (NYSE: AMRX) Look After It Drops -32.09% From Its Highs? – Marketing Sentinel
Home  »  Business   »  How Will Amneal Pharmaceuticals Inc. (NYSE: AMRX) ...

How Will Amneal Pharmaceuticals Inc. (NYSE: AMRX) Look After It Drops -32.09% From Its Highs?

During the last session, Amneal Pharmaceuticals Inc. (NYSE:AMRX)’s traded shares were 0.71 million, with the beta value of the company hitting 1.18. At the end of the trading day, the stock’s price was $5.64, reflecting an intraday loss of -1.57% or -$0.09. The 52-week high for the AMRX share is $7.45, that puts it down -32.09 from that peak though still a striking 30.85% gain since the share price plummeted to a 52-week low of $3.90. The company’s market capitalization is $1.70B, and the average intraday trading volume over the past 10 days was 0.7 million shares, and the average trade volume was 1.07 million shares over the past three months.

Amneal Pharmaceuticals Inc. (AMRX) received a consensus recommendation of an Overweight from analysts. That translates to a mean rating of 2.40. AMRX has a Sell rating from 1 analyst(s) out of 7 analysts who have looked at this stock. 2 analyst(s) recommend to Hold the stock while 1 suggest Overweight, and 3 recommend a Buy rating for it. 0 analyst(s) has rated the stock Underweight. Company’s earnings per share (EPS) for the current quarter are expected to be $0.2.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free


Amneal Pharmaceuticals Inc. (NYSE:AMRX) trade information

Amneal Pharmaceuticals Inc. (AMRX) registered a -1.57% downside in the last session and has traded in the green over the past 5 sessions. The stock plummet -1.57% in intraday trading to $5.64 this Friday, 10/15/21, hitting a weekly high. The stock’s 5-day price performance is 0.36%, and it has moved by 13.71% in 30 days. Based on these gigs, the overall price performance for the year is 11.90%. The short interest in Amneal Pharmaceuticals Inc. (NYSE:AMRX) is 4.53 million shares and it means that shorts have 5.06 day(s) to cover.

The consensus price target of analysts on Wall Street is $7.40, which implies an increase of 23.78% to the stock’s current value. The extremes of the forecast give a target low and a target high price of $6.00 and $9.00 respectively. As a result, AMRX is trading at a discount of -59.57% off the target high and -6.38% off the low.

Amneal Pharmaceuticals Inc. (AMRX) estimates and forecasts

Statistics show that Amneal Pharmaceuticals Inc. has outperformed its competitors in share price, compared to the industry in which it operates. Amneal Pharmaceuticals Inc. (AMRX) shares have gone down -0.70% during the last six months, with a year-to-date growth rate more than the industry average at 36.51% against 17.30. Yet analysts are ramping up their growth forecast for the fiscal year 2021. Revenue is predicted to grow 25.00% this quarter and then jump 57.10% in the quarter after that. In the rating firms’ projections, revenue will increase 7.20% compared to the previous financial year.

Revenue for the current quarter is expected to be $544.49 million as predicted by 7 analyst(s). Meanwhile, a consensus of 7 analyst(s) estimates revenue growth to $563.69 million by the end of Dec 2021. As per earnings report from last fiscal year’s results, sales for the corresponding quarters totaled $482.11 million and $510.03 million respectively. In this case, analysts expect current quarter sales to grow by 12.90% and then jump by 10.50% in the coming quarter.

An analysis of the company’s performance over the past 5 years shows that the company’s earnings shrunk an estimated -17.50%. While earnings are projected to return 95.40% in 2021, the next five years will return -12.10% per annum.

AMRX Dividends

Amneal Pharmaceuticals Inc. is due to release its next quarterly earnings on May 07. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.

Amneal Pharmaceuticals Inc. (NYSE:AMRX)’s Major holders

Amneal Pharmaceuticals Inc. insiders own 10.55% of total outstanding shares while institutional holders control 70.34%, with the float percentage being 78.63%. Fosun International Ltd is the largest shareholder of the company, while 223 institutions own stock in it. As of Mar 30, 2021, the company held over 21.52 million shares (or 14.47% of all shares), a total value of $144.84 million in shares.

The next largest institutional holding, with 16.21 million shares, is of Tpg Group Holdings (sbs) Advisors, Inc.’s that is approximately 10.90% of outstanding shares. At the market price on Mar 30, 2021, these shares were valued at $109.12 million.

>> 7 Top Picks for the Post-Pandemic Economy <<

Also, the Mutual Funds coming in first place with the largest holdings of Amneal Pharmaceuticals Inc. (AMRX) shares are Vanguard Specialized-Health Care Fund and Vanguard Total Stock Market Index Fund. Data provided on Jan 30, 2021 indicates that Vanguard Specialized-Health Care Fund owns about 9.31 million shares. This amounts to just over 6.26 percent of the company’s overall shares, with a $44.76 million market value. The same data shows that the other fund manager holds slightly less at 3.29 million, or about 2.22% of the stock, which is worth about $22.17 million.

Get The Best Stocks To Trade Every Day!

Join now to get the pre-market morning brief 100% free

Leave a Comment

Your email address will not be published. Required fields are marked *

On Key

Related Posts



Download Free eBook For



100% free. stop anytime no spam



Download Free eBook For



100% free. stop anytime no spam